BOZKURT, O. Et Al. 2019. The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy. Annals of Medical Research , vol.26, no.10 , 2089.

BOZKURT, O., FIRAT, S. T., DOĞAN, E., COŞAR, R., İNANÇ, M., & ÖZKAN, M., (2019). The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy. Annals of Medical Research , vol.26, no.10, 2089.

BOZKURT, OKTAY Et Al. "The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy," Annals of Medical Research , vol.26, no.10, 2089, 2019

BOZKURT, OKTAY Et Al. "The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy." Annals of Medical Research , vol.26, no.10, pp.2089, 2019

BOZKURT, O. Et Al. (2019) . "The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy." Annals of Medical Research , vol.26, no.10, p.2089.

@article{article, author={OKTAY BOZKURT Et Al. }, title={The impact of systemic inflammatory markers on survival in metastatic gastric cancer patients receiving first-line chemotherapy}, journal={Annals of Medical Research}, year=2019, pages={2089} }